Correlation Between Hookipa Pharma and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Viridian Therapeutics, you can compare the effects of market volatilities on Hookipa Pharma and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Viridian Therapeutics.
Diversification Opportunities for Hookipa Pharma and Viridian Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Hookipa and Viridian is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Viridian Therapeutics
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Viridian Therapeutics. In addition to that, Hookipa Pharma is 1.38 times more volatile than Viridian Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 2,747 in Viridian Therapeutics on September 26, 2024 and sell it today you would lose (816.00) from holding Viridian Therapeutics or give up 29.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Hookipa Pharma vs. Viridian Therapeutics
Performance |
Timeline |
Hookipa Pharma |
Viridian Therapeutics |
Hookipa Pharma and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and Viridian Therapeutics
The main advantage of trading using opposite Hookipa Pharma and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Viridian Therapeutics vs. Fate Therapeutics | Viridian Therapeutics vs. Caribou Biosciences | Viridian Therapeutics vs. Karyopharm Therapeutics | Viridian Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |